Article
GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer
16 Dec 2019
Abstract excerpt
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney, and its diagnosis and prognosis still lack reliable biomarkers. Glutathione peroxidase 1 (GPX1) has been identified to be highly expressed in a variety of human malignancies. However, few studies have studied the expression of GPX1 and its biological functions in RCC. We attempted to assess the potential of GPX1 as a promising biomarker...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
